You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 275 No. 4, January 24, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (159)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Challenges of Emerging Infectious Diseases

Development and Spread of Multiply-Resistant Bacterial Pathogens

Fred C. Tenover, PhD; James M. Hughes, MD

JAMA. 1996;275(4):300-304.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE LIST of emerging infectious diseases is an intriguing constellation of new entities (a previously unrecognized Hantavirus), recognized pathogens that have caused recent outbreaks of unprecedented size (Cryptosporidium in municipal water supplies), outbreaks that have culminated in a reassessment of the issue of food safety (Escherichia coli O157:H7), and traditional nosocomial and community-acquired infections that, due to their resistance to multiple antimicrobial agents, have suggested the possibility of a postantibiotic era.1,2Enterococcus faecium, Streptococcus pneumoniae, and Mycobacterium tuberculosis are just a few of the organisms that have become considerably more difficult to treat due to increasing drug resistance. Examples of the types of resistant bacteria that have emerged around the world are shown in Figure 1, while specific examples of emerging resistance problems in the United States are shown in Figure 2. Clearly, the emergence of resistant organisms has been a global phenomenon. A recent Institute of Medicine report . . . [Full Text PDF of this Article]


Author Affiliations

From the National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.


Footnotes

This article is one of a series addressing emerging and reemerging global microbial threats.

Use of trade names in this article is for identification purposes only and does not constitute endorsement by the US Public Health Service or the US Department of Health and Human Services.

Reprint requests to Nosocomial Pathogens Laboratory Branch (G-08), National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333 (Dr Tenover).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.